HLB Therapeutics Co.,Ltd. Logo

HLB Therapeutics Co.,Ltd.

Biopharmaceutical firm developing drugs for rare diseases in oncology and ophthalmology.

115450 | KO

Overview

Corporate Details

ISIN(s):
KR7115450009
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 정자일로 248, 성남시

Description

HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-11-01 00:00
[기재정정]주주총회소집결의
Korean 28.7 KB
2021-11-01 00:00
[기재정정]주주총회소집공고
Korean 149.0 KB
2021-11-01 00:00
[기재정정]의결권대리행사권유참고서류
Korean 72.7 KB
2021-10-29 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.2 KB
2021-10-28 00:00
주요사항보고서(소송등의제기)
Korean 6.1 KB
2021-10-27 00:00
[기재정정]주주총회소집공고
Korean 183.4 KB
2021-10-27 00:00
[기재정정]주주총회소집결의
Korean 32.7 KB
2021-10-27 00:00
[기재정정]의결권대리행사권유참고서류
Korean 103.4 KB
2021-10-27 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 67.4 KB
2021-10-27 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 89.5 KB
2021-10-27 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 57.8 KB
2021-10-27 00:00
[기재정정]소송등의제기ㆍ신청(경영권분쟁소송)(주주총회개최금지)
Korean 16.8 KB
2021-10-27 00:00
소송등의판결ㆍ결정(신주발행금지가처분)
Korean 5.5 KB
2021-10-27 00:00
소송등의판결ㆍ결정(주주총회개최금지)
Korean 6.2 KB
2021-10-25 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 61.3 KB

Automate Your Workflow. Get a real-time feed of all HLB Therapeutics Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB Therapeutics Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB Therapeutics Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.